Researchers at the University of California, Los Angeles (UCLA) are developing a gene-editing therapy — designed to be delivered as…
Articles by Andrea Lobo, PhD
Poor sleep quality is linked to a higher risk of malnutrition in adolescents with cystic fibrosis (CF), suggesting that…
Discoveries into the process underlying protein organization on cell membranes could ultimately lead to new ways to treat cystic fibrosis…
Volatile organic compounds (VOCs) found in breath may be used as biomarkers of lung function and treatment response in children with…
The U.K. Medicines and Healthcare Products Regulatory Agency approved Alyftrek (vanzacaftor, tezacaftor, and deutivacaftor) as a cystic fibrosis…
Among children with cystic fibrosis (CF), starting the approved oral therapy Orkambi (ivacaftor/lumacaftor) led to favorable changes in…
In adults with cystic fibrosis (CF), six of months treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor) led to lower levels of biomarkers…
Oransi has donated air purifiers to help people with cystic fibrosis (CF) affected by smoke-filled air from the…
Clarametyx Biosciences has announced an investment from Kineticos AMR Accelerator (KAMRA) Fund to support the development of CMTX-101,…
People with cystic fibrosis (CF) saw sustained reductions in the use of several other CF therapies after two years…